First Time Loading...

LogicBio Therapeutics Inc
NASDAQ:LOGC

Watchlist Manager
LogicBio Therapeutics Inc Logo
LogicBio Therapeutics Inc
NASDAQ:LOGC
Watchlist
Price: 5.57 USD 169.08% Market Closed
Updated: May 15, 2024

Balance Sheet

Balance Sheet Decomposition
LogicBio Therapeutics Inc

Current Assets 32.8m
Cash & Short-Term Investments 30.8m
Other Current Assets 2m
Non-Current Assets 5.8m
PP&E 5.2m
Other Non-Current Assets 622k
Current Liabilities 16.4m
Accounts Payable 1.1m
Accrued Liabilities 3.7m
Other Current Liabilities 11.7m
Non-Current Liabilities 6.4m
Long-Term Debt 2.6m
Other Non-Current Liabilities 3.8m

Balance Sheet
LogicBio Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021
Assets
Cash & Cash Equivalents
2
25
81
33
70
53
Cash Equivalents
2
25
81
33
70
53
Short-Term Investments
0
0
0
18
0
0
Total Receivables
0
0
0
0
0
0
Accounts Receivables
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
Other Current Assets
0
1
1
2
2
2
Total Current Assets
2
26
82
53
73
56
PP&E Net
0
0
1
2
7
6
PP&E Gross
0
0
1
2
7
6
Accumulated Depreciation
0
0
0
0
1
1
Other Long-Term Assets
0
0
0
1
1
1
Total Assets
2
N/A
26
+1 189%
83
+217%
56
-33%
81
+45%
63
-22%
Liabilities
Accounts Payable
0
1
1
1
0
1
Accrued Liabilities
1
1
2
3
4
5
Short-Term Debt
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
2
3
Other Current Liabilities
0
0
0
0
0
11
Total Current Liabilities
1
2
3
4
6
20
Long-Term Debt
0
0
0
10
8
5
Other Liabilities
0
0
0
0
5
7
Total Liabilities
1
N/A
2
+86%
3
+57%
13
+397%
19
+44%
32
+67%
Equity
Common Stock
4
33
0
0
0
0
Retained Earnings
4
10
27
67
100
140
Additional Paid In Capital
1
1
107
110
161
171
Other Equity
0
0
0
0
0
0
Total Equity
1
N/A
24
+2 104%
80
+228%
42
-47%
61
+45%
31
-50%
Total Liabilities & Equity
2
N/A
26
+1 189%
83
+217%
56
-33%
81
+45%
63
-22%
Shares Outstanding
Common Shares Outstanding
21
21
22
23
32
33

See Also

Discover More